Medical experts have identified four primary ways GLP-1 drugs trigger stomach paralysis: Excessive GLP-1 receptor activation: Continuous stimulation causes extreme delays progressing to paralysis of stomach muscle function Disrupted stomach pacemaker cells: GLP-1 drugs affect specialized cells generating electrical rhythms, causing gastric arrhythmia Impaired pyloric sphincter function: Prevents proper valve relaxation between stomach and small intestine, creating functional obstruction Accumulation effects: Duration of use correlates with severity, as prolonged exposure causes progressive nerve dysfunction Healthy individuals empty approximately 40-90% of meals within one hour, retaining less than 10% after four hours
10.1517/17425247.2012.666968 192 RajanalaS.MaymoneM
New one-day industry event will unveil original research and bring together retail, CPG, and technology leaders to examine how GLP-1 adoption is reshaping the grocery basket, consumer behavior, and future growth strategies Chicago, July 16, 2026 As GLP-1 adoption accelerates, retailers and consumer brands are confronting what could become one of the most significant changes to the grocery basket in decades
Cherney DZI, Cooper ME, Tikkanen I, et al
Cardiovascular and metabolic diseases including obesity remain important areas of unmet medical need, and we plan to continue applying our global capabilities to advance a pipeline of investigational treatments that have the potential to fill critical gaps in patient care, including continued development of our oral GIPR antagonist candidate and other earlier obesity programs, said Chris Boshoff, MD, PhD, Chief Scientific Officer and President, Research and Development at Pfizer
